When you seek a dementia second opinion, expect a serum vitamin B12 test, a blood test that measures B12 in your blood. It screens for B12 deficiency as a possible reversible cause of confusion and memory loss, while its accuracy depends on preparation and follow-up testing. Dementia evaluations routinely include this test because B12 deficiency can mimic dementia and must be ruled out before diagnosing lasting dementia, according to the Merck Manual in its dementia evaluation guidance. Low B12 can injure brain and spinal-cord white matter and nerves, causing numbness, weakness, gait trouble, paranoia, confusion, and delirium, sometimes without anemia.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- Why does a second opinion revisit B12?
- How accurate is one B12 result?
- How should you prepare?
- What happens after a low or borderline result?
Why does a second opinion revisit B12?
A second opinion checks whether a reversible cause was missed or incompletely tested. The first diagnosis may have rested on symptoms alone, while confusion, memory loss, and behavior change also occur with B12 deficiency. A fresh reviewer will place B12 results beside symptom timing, medicines, diet, stomach surgery, and alcohol use.
The reviewer also looks for nerve and spinal-cord clues. The MSD Manual Professional Edition describes numbness, weakness, unsteady gait, paranoia, confusion, and delirium from B12 deficiency. These signs can appear without anemia, so a normal blood count does not remove the need for B12 review.
How accurate is one B12 result?
A single serum B12 result can mislead. The UK NICE guideline NG239 treats under 180 ng/L as confirmed deficiency and 180-350 ng/L as indeterminate, according to NICE in its B12 deficiency recommendations. Indeterminate results need confirmatory methylmalonic acid, called MMA, or homocysteine testing.
MMA helps show functional deficiency. MedlinePlus explains that B12 normally breaks MMA down during protein metabolism, so low B12 lets excess MMA build up in blood or urine. High-dose biotin, or vitamin B7, can also distort immunoassay results, causing false highs or lows. ARUP Laboratories, summarizing FDA safety communications from 2017 and 2019, advises patients to disclose biotin and pause it before testing as directed by the lab.
How should you prepare?
MedlinePlus instructs patients to fast 6-8 hours before the B12 blood test and to report medicines that can alter results, described in its B12 test preparation instructions. Tell the clinic about metformin, proton-pump inhibitors, H2 blockers, colchicine, and seizure medicines.
Do not stop a prescription on your own to prepare. Ask the ordering clinician what to hold, for how long, and whether morning testing helps.
- Fast 6-8 hours as instructed, with water only unless told otherwise
- List all prescriptions, vitamins, B-complex, biotin, and antacids
- Ask when to pause biotin and confirm the exact hold time
- Bring prior B12, MMA, homocysteine, folate, and blood-count results
What happens after a low or borderline result?
When deficiency is confirmed, guidelines direct testing for the cause. NICE NG239 points to anti-intrinsic factor antibodies when autoimmune gastritis is suspected. Treatment uses oral or injected B12, not folate alone, because folate alone can hide anemia while nerve injury continues, as NICE and the MSD Manual describe.
Response takes time, and delay matters. The MSD Manual Professional Edition warns that long-standing or severe neurologic and cognitive injury may persist or prove irreversible despite replacement. Bring symptom start dates, prior B12 results, supplement doses, stomach or bowel history, and any change after prior B12 treatment.





